Free tool
FAERS Monitor: Starjemza
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming BLA 761419 or its brand name (Starjemza, Ustekinumab-Hmny). Reports on generic versions are filed under their own applications.
Reports
1
Serious
1
100% of reports
Hospitalization
1
Death reported
0
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- blood glucose increased1
- drug ineffective1
- dyspnoea1
- hepatic cirrhosis1
- nasopharyngitis1
- pain1
- pain in extremity1
- peripheral swelling1
- polyp1
- psoriatic arthropathy1
- skin reaction1
- therapy interrupted1
- tremor1
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2026 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,158 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| polyp | 1 | 3212.9 | 3136.1 | 802 |
| skin reaction | 1 | 1493.0 | 1468.6 | 372 |
| hepatic cirrhosis | 1 | 1119.9 | 1104.0 | 279 |
| psoriatic arthropathy | 1 | 518.2 | 513.2 | 129 |
| therapy interrupted | 1 | 294.3 | 292.2 | 73 |
| peripheral swelling | 1 | 136.5 | 135.9 | 33 |
| tremor | 1 | 126.7 | 126.1 | 31 |
| nasopharyngitis | 1 | 114.1 | 113.6 | 28 |
| blood glucose increased | 1 | 111.6 | 111.1 | 27 |
| pain in extremity | 1 | 71.4 | 71.1 | 17 |
| dyspnoea | 1 | 37.2 | 37.1 | 9 |
| pain | 1 | 34.2 | 34.2 | 8 |
| drug ineffective | 1 | 16.0 | 15.9 | 3 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.